JB/CALL/IDORSIA/14.5/0.1429/21.06.24 | Market Closed - Swiss Exchange 11:20:00 2024-04-12 am EDT | ||
| 0.011 CHF | -8.33% |
|
| 1 month | -59.26% | ||
| 3 months | -56.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IDORSIA LTD
Latest news about IDORSIA LTD
More news
Static data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | IDORSIA LTD |
| Issuer | Bank Julius Bär |
| IDIRJB | |
| ISIN | CH1225609580 |
| Date issued | 2023-01-04 |
| Strike | 14.5 CHF |
| Maturity | 2024-06-21 (34 Days) |
| Parity | 7 : 1 |
| Emission price | 0.67 CHF |
| Emission volume | N/A |
| Settlement | both |
| Currency | CHF |
Technical Indicators
| Highest since issue | 0.98 CHF |
|---|---|
| Lowest since issue | 0.011 CHF |
| Spread | 0.01 CHF |
| Spread % | 90.91% |
Company Profile
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.
Sector
-
Consensus: Idorsia Ltd
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
8
Last Close Price
2.22
CHF
Average target price
1.724
CHF
Spread / Average Target
-22.35%
- Stock Market
- Warrants
- IDIRJB Warrant
